INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
154 hedge funds and large institutions have $1.15B invested in Insys Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 53 increasing their positions, 52 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more call options, than puts
Call options by funds: $17M | Put options by funds: $16.1M
2% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 52
Holders
154
Holding in Top 10
3
Calls
$17M
Puts
$16.1M
Top Buyers
| 1 | +$118M | |
| 2 | +$23.8M | |
| 3 | +$16.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.9M |
| 5 |
VM
Valinor Management
New York
|
+$8.43M |
Top Sellers
| 1 | -$26.2M | |
| 2 | -$23.3M | |
| 3 | -$20.9M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$19.7M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$17.7M |